REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Trial ID or NCT#

NCT07223307

Status

recruiting iconRECRUITING

Purpose

Single arm unblinded study of simulation-free MRI-guided SABR with adaptive replanning in one session for treatment of patients with liver cancers

Official Title

Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Erqi Pollom
Erqi Pollom
Radiation oncologist
Sue and Bob McCollum Professor and Professor, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.

Contact

Eleanor Brown
650-497-8966

SEND MESSAGE

View on ClinicalTrials.gov